These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 7910172)

  • 1. Processing of urushiol (poison ivy) hapten by both endogenous and exogenous pathways for presentation to T cells in vitro.
    Kalish RS; Wood JA; LaPorte A
    J Clin Invest; 1994 May; 93(5):2039-47. PubMed ID: 7910172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urushiol (poison ivy)-triggered suppressor T cell clone generated from peripheral blood.
    Kalish RS; Morimoto C
    J Clin Invest; 1988 Sep; 82(3):825-32. PubMed ID: 2458387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of hapten-specific tolerance of human CD8+ urushiol (poison ivy)-reactive T lymphocytes.
    Kalish RS; Wood JA
    J Invest Dermatol; 1997 Mar; 108(3):253-7. PubMed ID: 9036920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enrichment and function of urushiol (poison ivy)-specific T lymphocytes in lesions of allergic contact dermatitis to urushiol.
    Kalish RS; Johnson KL
    J Immunol; 1990 Dec; 145(11):3706-13. PubMed ID: 2147199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of human T-lymphocyte clones to study T-cell function in allergic contact dermatitis to urushiol.
    Kalish RS
    J Invest Dermatol; 1990 Jun; 94(6 Suppl):108S-111S. PubMed ID: 1693644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitation and cloning of human urushiol specific peripheral blood T-cells: isolation of urushiol triggered suppressor T-cells.
    Kalish RS; Morimoto C
    J Invest Dermatol; 1989 Jan; 92(1):46-52. PubMed ID: 2521239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro studies of poison oak immunity. II. Effect of urushiol analogues on the human in vitro response.
    Byers VS; Castagnoli N; Epstein WL
    J Clin Invest; 1979 Nov; 64(5):1449-56. PubMed ID: 315415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on poison ivy. In vitro lymphocyte transformation by urushiol-protein conjugates.
    Dupuis G
    Br J Dermatol; 1979 Dec; 101(6):617-24. PubMed ID: 161173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro studies of poison oak immunity. I. In vitro reaction of human lymphocytes to urushiol.
    Byers VS; Epstein WL; Castagnoli N; Baer H
    J Clin Invest; 1979 Nov; 64(5):1437-48. PubMed ID: 315414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preservation of allergic contact dermatitis to poison ivy (urushiol) in late HIV disease. The implications and relevance to immunotherapy with contact allergens.
    Smith KJ; Skelton HG; Nelson A; Wagner KF; Hackley BE
    Dermatology; 1997; 195(2):145-9. PubMed ID: 9310722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunologic studies of poisonous Anacardiaceae: I. Production of tolerance and desensitization to poison Ivy and oak urushiols using esterified urushiol derivatives in guinea pigs.
    Watson ES; Murphy JC; Wirth PW; Waller CW; Elsohly MA
    J Invest Dermatol; 1981 Mar; 76(3):164-70. PubMed ID: 6453903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of antigen-specific CD8+ cytolytic T cells by the exogenous bacterial antigen streptolysin O in rhesus monkeys.
    Chizzolini C; Millet PG; Olsen-Rasmussen MA; Collins WE
    Eur J Immunol; 1991 Nov; 21(11):2727-33. PubMed ID: 1682153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct, MHC-dependent presentation of the drug sulfamethoxazole to human alphabeta T cell clones.
    Schnyder B; Mauri-Hellweg D; Zanni M; Bettens F; Pichler WJ
    J Clin Invest; 1997 Jul; 100(1):136-41. PubMed ID: 9202065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of human CD8+ alpha beta TCR+ cells by Mycobacterium tuberculosis via an alternate class I MHC antigen-processing pathway.
    Canaday DH; Ziebold C; Noss EH; Chervenak KA; Harding CV; Boom WH
    J Immunol; 1999 Jan; 162(1):372-9. PubMed ID: 9886409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition by brefeldin A of presentation of exogenous protein antigens to MHC class II-restricted T cells.
    Adorini L; Ullrich SJ; Appella E; Fuchs S
    Nature; 1990 Jul; 346(6279):63-6. PubMed ID: 2366863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of nickel-specific CD4+ T lymphocytes in the absence of professional antigen-presenting cells.
    Nasorri F; Sebastiani S; Mariani V; De Pità O; Puddu P; Girolomoni G; Cavani A
    J Invest Dermatol; 2002 Jan; 118(1):172-9. PubMed ID: 11851891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New GLC analysis of urushiol congeners in different plant parts of poison ivy, Toxicodendron radicans.
    Craig JC; Waller CW; Billets S; Elsohly MA
    J Pharm Sci; 1978 Apr; 67(4):483-5. PubMed ID: 641754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presentation of beta-cell antigens to CD4+ and CD8+ T cells of non-obese diabetic mice.
    Shimizu J; Kanagawa O; Unanue ER
    J Immunol; 1993 Aug; 151(3):1723-30. PubMed ID: 8101546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptome profiling reveals Th2 bias and identifies endogenous itch mediators in poison ivy contact dermatitis.
    Liu B; Tai Y; Liu B; Caceres AI; Yin C; Jordt SE
    JCI Insight; 2019 Jun; 5(14):. PubMed ID: 31184997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of the contact sensitivity response to urushiol with anti-urushiol monoclonal antibody ALG 991.
    Baldwin RW; Clegg JA; Curran AC; Austin EB; Khan T; Ma Y; Gunn B; Hudecz F; Byers VS; Lepoittevin JP; Price MR
    Arch Dermatol Res; 1999 Dec; 291(12):652-8. PubMed ID: 10651166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.